Premium
Bone marrow necrosis in a patient with acute myeloblastic leukemia during administration of G‐CSF and rapid hematologic recovery after allotransplantation of peripheral blood stem cells
Author(s) -
Katayama Yoshio,
Deguchi Seigo,
Shinagawa Katsuji,
Teshima Takanori,
Notohara Kenji,
Taguchi Koji,
Omoto Eijiro,
Harada Mine
Publication year - 1998
Publication title -
american journal of hematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.456
H-Index - 105
eISSN - 1096-8652
pISSN - 0361-8609
DOI - 10.1002/(sici)1096-8652(199803)57:3<238::aid-ajh11>3.0.co;2-6
Subject(s) - medicine , bone marrow , total body irradiation , acute myeloblastic leukemia , cyclophosphamide , haematopoiesis , leukemia , necrosis , allotransplantation , acute leukemia , pathology , stem cell , transplantation , chemotherapy , surgery , biology , genetics
Allogeneic peripheral blood stem cell transplantation from an HLA‐identical sibling was performed for a 38‐year‐old male with refractory acute myeloblastic leukemia. The patient was conditioned with total body irradiation (TBI) and high‐dose cytosine arabinoside (Ara‐C). G‐CSF (300 μg/body) was started for priming of residual leukemic cells 24 hrbefore the beginning of TBI (day −9). However, intolerable generalized bone pain appeared shortly after the start of first dose of G‐CSF, and persisted for 3 days in spite of the cessation of G‐CSF. Posttransplant hematopoietic engraftment was very rapid. Bone marrow biopsy specimens on day 14 and 30 showed typical bone marrow necrosis histologically. This is the first case of bone marrow necrosis during administration of G‐CSF, and our experience suggests that PBSC could repopulate hematopoiesis in spite of severe bone marrow necrosis. Am. J. Hematol. 57:238–240, 1998. © 1998 Wiley‐Liss, Inc.